E-commerce Contacto
/contact

Hawes, Endosonografía 4 edición

Robert H. Hawes


  1. Sección II: Mediastino
  2. Cap. 7 EUS y EBUS en cáncer pulmonar de células no pequeñas
Regresar

Capítulo 7 EUS y EBUS en cáncer pulmonar de células no pequeñas

  1. Howington JA, Blum MG, Chang AC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer,. 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e278S–e313S.
  2. Ramnath N, Dilling TJ, Harris LJet al., et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer,. 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2013;143:e314S–e340S.
  3. Schmidt-Hansen M, Baldwin DR, Hasler E. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014. Cd009519.
  4. Silvestri GA, Gonzalez AV, Jantz MAet al., et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer. 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2013;143:e211S–e250S.
  5. De LP, Dooms C, Kuzdzal Jet al., et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45:787–798.
  6. Vilmann P, Clementsen PF, Colella Set al., et al. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: european society of gastrointestinal endoscopy (ESGE) guideline, in cooperation with the european respiratory society (ERS) and the european society of thoracic surgeons (ESTS). Endoscopy. 2015;47. c1.
  7. Annema JT, van Meerbeeck JP, Rintoul RCet al., et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA. 2010;304:2245–2252.
  8. Vansteenkiste J, De RD, Eberhardt WEet al., et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl 6):vi89–vi98.
  9. Annema JT, Veselic M, Rabe KF. EUS-guided FNA of centrally located lung tumours following a non-diagnostic bronchoscopy. Lung Cancer. 2005;48:357–361. discussion 63–64.
  10. Korevaar DA, Colella S, Spijker Ret al., et al. Esophageal endosonography for the diagnosis of intrapulmonary tumors: a systematic review and meta-analysis. Respiration. 2017;93:126–137.
  11. Venuta F, Rendina EA, Ciriaco Pet al., et al. Computed tomography for preoperative assessment of T3 and T4 bronchogenic carcinoma. Eur J Cardiothorac Surg. 1992;6:238–241.
  12. Pieterman RM, van Putten JW, Meuzelaar JJet al., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254–261.
  13. Kuijvenhoven JC., Crombag L., Breen D.P., et al. Esophageal ultrasound (EUS) assessment of T4 status in NSCLC patients. Lung Cancer. 2017;114:50–55.
  14. Konge L, Vilmann P, Clementsen Pet al., et al. Reliable and valid assessment of competence in endoscopic ultrasonography and fine-needle aspiration for mediastinal staging of non-small cell lung cancer. Endoscopy. 2012;44:928–933.
  15. Goldstraw P, Chansky K, Crowley Jet al., et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
  16. von Bartheld MB, Rabe KF, Annema JT. Transaortic EUS-guided FNA in the diagnosis of lung tumors and lymph nodes. Gastrointest Endosc. 2009;69:345–349.
  17. Liberman M, Duranceau A, Grunenwald Eet al., et al. New technique performed by using EUS access for biopsy of para-aortic (station 6) mediastinal lymph nodes without traversing the aorta (with video). Gastrointest Endosc. 2011;73:1048–1051.
  18. Catalano MF, Sivak Jr. MV, Rice T. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–446.
  19. Fujiwara T, Yasufuku K, Nakajima Tet al., et al. The utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with lung cancer: a standard endobronchial ultrasound image classification system. Chest. 2010;138:641–647.
  20. Gill KR, Ghabril MS, Jamil LHet al., et al. Endosonographic features predictive of malignancy in mediastinal lymph nodes in patients with lung cancer. Gastrointest Endosc. 2010;72:265–271.
  21. Memoli JS, El-Bayoumi E, Pastis NJet al., et al. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011;140:1550–1556.
  22. Saftoiu A, Vilmann P, Ciurea Tet al., et al. Dynamic analysis of EUS used for the differentiation of benign and malignant lymph nodes. Gastrointest Endosc. 2007;66:291–300.
  23. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003;123:157s–166s.
  24. Schmulewitz N, Wildi SM, Varadarajulu Set al., et al. Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc. 2004;59:205–212.
  25. Janssen J, Dietrich CF, Will U, Greiner L. Endosonographic elastography in the diagnosis of mediastinal lymph nodes. Endoscopy. 2007;39:952–957.
  26. LeBlanc JK, Ciaccia D, Al-Assi MTet al., et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc. 2004;59:475–481.
  27. Wallace MB, Kennedy T, Durkalski Vet al., et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc. 2001;54:441–447.
  28. Aerts JG, Kloover J, Los J. EUS-FNA of enlarged necrotic lymph nodes may cause infectious mediastinitis. J Thorac Oncol. 2008;3:1191–1193.
  29. Micames CG, McCrory DC, Pavey DA. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest. 2007;131:539–548.
  30. Annema JT, Versteegh MI, Veselic Met al., et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005;294:931–936.
  31. LeBlanc JK, Devereaux BM, Imperiale TFet al., et al. Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography. Am J Respir Crit Care Med. 2005;171:177–182.
  32. Wallace MB, Ravenel J, Block MIet al., et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg. 2004;77:1763–1768.
  33. Mody MK, Kazerooni EA, Korobkin M. Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr. 1995;19:434–439.
  34. Osman Y, El-Mekresh M, Gomha AMet al., et al. Percutaneous adrenal biopsy for indeterminate adrenal lesion: complications and diagnostic accuracy. Urol Int. 2010;84:315–318.
  35. Schuurbiers OC, Tournoy KG, Schoppers HJet al., et al. EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer. Lung Cancer. 2011;73:310–315.
  36. Crombag LMMJ. EUS-B-FNA vs conventional EUS-FNA for left adrenal gland analysis inlung cancer patients. In: Artur Szlubowski JAS, Schuurbiers O, Korevaar DA, Bonta PI, Annema JT, eds. Lung Cancer. ; 2017.
  37. Hollerbach S, Willert J, Topalidis Tet al., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment. Endoscopy. 2003;35:743–749.
  38. Prasad P, Schmulewitz N, Patel Aet al., et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc. 2004;59:49–53.
  39. Herth FJ, Krasnik M, Kahn Net al., et al. Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest. 2010;138:790–794.
  40. Kang HJ, Hwangbo B, Lee GKet al., et al. EBUS-centred versus EUS-centred mediastinal staging in lung cancer: a randomised controlled trial. Thorax. 2014;69:261–268.
  41. Szlubowski A, Soja J, Kocon Pet al., et al. A comparison of the combined ultrasound of the mediastinum by use of a single ultrasound bronchoscope versus ultrasound bronchoscope plus ultrasound gastroscope in lung cancer staging: a prospective trial. Interact Cardiovasc Thorac Surg. 2012;15:442–446. discussion 6.
  42. Crombag LM, Annema JT. Left adrenal gland analysis in lung cancer patients using the endobronchial ultrasound scope: a feasibility trial. Respiration. 2016;91:235–240.
  43. Casal RF, Staerkel GA, Ost Det al., et al. Randomized clinical trial of endobronchial ultrasound needle biopsy with and without aspiration. Chest. 2012;142:568–573.
  44. Lee HS, Lee GK, Lee HSet al., et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008;134:368–374.
  45. von Bartheld MB, van BA, Annema JT. Complication rate of endosonography (endobronchial and endoscopic ultrasound): a systematic review. Respiration. 2014;87:343–351.
  46. Nakajima T, Yasufuku K, Fujiwara Tet al., et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrapulmonary lesions. J Thorac Oncol. 2008;3:985–988.
  47. Tournoy KG, Rintoul RC, van Meerbeeck JPet al., et al. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer. 2009;63:45–49.
  48. Konge L, Clementsen PF, Ringsted Cet al., et al. Simulator training for endobronchial ultrasound: a randomised controlled trial. Eur Respir J. 2015;46:1140–1149.
  49. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax. 2009;64:757–762.
  50. Gu P, Zhao YZ, Jiang LYet al., et al. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer. 2009;45:1389–1396.
  51. Korevaar DA, Crombag LM, Cohen JFet al., et al. Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: a systematic review and meta-analysis. Lancet Respir Med. 2016;4:960–968.
  52. Ernst A, Eberhardt R, Krasnik M, Herth FJ. Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer. J Thorac Oncol. 2009;4:947–950.
  53. van der Heijden EH, Casal RF, Trisolini Ret al., et al. Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration. 2014;88:500–517.
  54. Rintoul RC, Skwarski KM, Murchison JTet al., et al. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J. 2005;25:416–421.
  55. Szlubowski A, Zielinski M, Soja Jet al., et al. A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging—a prospective trial. Eur J Cardiothorac Surg. 2010;37:1175–1179.
  56. Vilmann P, Krasnik M, Larsen SSet al., et al. Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions. Endoscopy. 2005;37:833–839.
  57. Wallace MB, Pascual JM, Raimondo Met al., et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA. 2008;299:540–546.
  58. Hwangbo B, Lee GK, Lee HSet al., et al. Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest. 2010;138:795–802.
  59. Oki M, Saka H, Ando Met al., et al. Transbronchial vs transesophageal needle aspiration using an ultrasound bronchoscope for the diagnosis of mediastinal lesions: a randomized study. Chest. 2015;147:1259–1266.
  60. Cerfolio RJ, Bryant AS, Eloubeidi MA. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg. 2007;84:940–945.
  61. Kinsey CM, Arenberg DA. Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging. Am J Respir Crit Care Med. 2014;189:640–649.
  62. Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: novel concepts. Lancet Oncol. 2012;13:e221–e229.
  63. De Wever W, Stroobants S, Coolen J, Verschakelen JA. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration. Eur Respir J. 2009;33:201–212.
  64. Stather DR, Maceachern P, Chee Aet al., et al. Trainee impact on advanced diagnostic bronchoscopy: an analysis of 607 consecutive procedures in an interventional pulmonary practice. Respirology (Carlton, Vic). 2013;18:179–184.
  65. Farr A, Clementsen P, Herth Fet al., et al. Endobronchial ultrasound: launch of an ERS structured training programme. Breathe (Sheffield, England). 2016;12:217–220.
  66. Annema JT, Bohoslavsky R, Burgers Set al., et al. Implementation of endoscopic ultrasound for lung cancer staging. Gastrointest Endosc. 2010;71:64–70. e1.
  67. Wijmans L, de Bruin DM, Meijer SL, Annema JT. Real-time optical biopsy of lung cancer. Am J Respir Crit Care Med. 2016;194:e10–e11.
  68. Wijmans L, d’Hooghe JN, Bonta PI, Annema JT. Optical coherence tomography and confocal laser endomicroscopy in pulmonary diseases. Curr Opin Pulm Med. 2017;23:275–283.
  69. Tournoy KG, De Ryck F, Vanwalleghem LRet al., et al. Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial. Am J Respir Crit Care Med. 2008;177:531–535.
Regresar